Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Research & Development (2020 - 2025)

Pulse Biosciences has reported Research & Development over the past 6 years, most recently at $11.4 million for Q3 2025.

  • Quarterly results put Research & Development at $11.4 million for Q3 2025, up 47.9% from a year ago — trailing twelve months through Sep 2025 was $44.5 million (up 50.84% YoY), and the annual figure for FY2024 was $32.3 million, up 16.33%.
  • Research & Development for Q3 2025 was $11.4 million at Pulse Biosciences, down from $12.1 million in the prior quarter.
  • Over the last five years, Research & Development for PLSE hit a ceiling of $12.1 million in Q2 2025 and a floor of $300000.0 in Q1 2021.
  • Median Research & Development over the past 5 years was $6.8 million (2022), compared with a mean of $7.1 million.
  • Biggest five-year swings in Research & Development: plummeted 95.15% in 2021 and later soared 2156.33% in 2022.
  • Pulse Biosciences' Research & Development stood at $5.7 million in 2021, then decreased by 27.62% to $4.1 million in 2022, then soared by 90.45% to $7.8 million in 2023, then soared by 36.71% to $10.7 million in 2024, then grew by 6.86% to $11.4 million in 2025.
  • The last three reported values for Research & Development were $11.4 million (Q3 2025), $12.1 million (Q2 2025), and $10.3 million (Q1 2025) per Business Quant data.